Addressing the Prescription Drug Affordability Crisis: A Golden Opportunity for State Lawmakers
By Justin Mendoza, Frederick Isasi,
02.19.2020
Prescription drug affordability is a top concern for U.S. voters across the political spectrum and throughout the nation. While the federal government and Congress continue to debate the issue, state lawmakers can and should take the matter into their own hands. Establishing an independent body to assess prescription drug affordability is a new option for states that has the potential to significantly curtail prescription drug pricing abuses and lower costs for families, taxpayers, and businesses. Lawmakers in Maine and Maryland already have enacted versions of such legislation. This fact sheet provides a brief overview of the urgent need for state action on prescription drug prices and key insights about this potentially powerful approach to tackling the issue. Click the download button below to view the fact sheet.
key resources
Maryland’s Path to a Prescription Drug Affordability Board
07.01.2019 / Insights Column
State Efforts to Rein in High Drug Prices in the 2019 Session
07.29.2019 / Report
How High Prescription Drug Costs Harm Families
05.17.2019 / Fact Sheet